NSE filing, NSE: NEOCHEM. Summary written from the filing by ALFA Finder's alert engine.
Neochem Bio Solutions Ltd: key numbers
- Share price
- ₹105.10
- Market cap
- ₹179.9 Cr
- Revenue (annual)
- ₹110.7 Cr
- Net profit (annual)
- ₹12.03 Cr
- P/E (TTM)
- 15.0×Sector 34.1×
- Promoter holding
- 66.88%
- FII holding
- 0.18%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Neochem Bio Solutions Ltd
All →Neochem Bio Solutions Earnings Call Transcript: Key Takeaways
Neochem Bio Solutions is a specialty chemical manufacturer reporting strong H1 FY25 growth, achieving ₹4,718 Lakh income with 18.75% EBITDA margin, focusing on Textile, HPC, and sustainable bio-based formulations.
Neochem Bio Solutions Investor Presentation: Key Takeaways
H1 FY27 revenue ₹68.9 cr (+50% y-o-y), PAT ₹7.8 cr (+43%), but EBITDA margin fell to 18.0% from 21.7%. Strategy centres on diversification and bio-based chemistries.
Neochem Bio Solutions Management Change
Neochem Bio Solutions appointed Harshit Shah as CFO and Vikram Nair as CCO effective October 27. Solanki was redesigned from CFO to Senior VP Finance.
Neochem Bio Solutions H1 FY27 Results: Net Profit ₹7.8 Cr, Up 41.8% YoY
Neochem Bio Solutions Ltd reported revenue from operations of ₹68.9 Cr (+50.4% YoY) and net profit of ₹7.8 Cr (+41.8% YoY) for H1 FY27.
- Key figure
- Net profit ₹7.8 Cr · +41.8% YoY
Neochem Bio Solutions Annual General Meeting
Neochem Bio Solutions Limited held its 9th Annual General Meeting on September 21, 2026, where management reviewed the company's performance and discussed future business strategies.
Neochem Bio Solutions Promoter Buying: ₹0.14 Cr
Promoter Swapnil R. Makati acquired 1,200 equity shares of Neochem Bio Solutions Limited for ₹0.14 Crore via an on-market purchase.
- Value
- ₹0.14 Cr
- Promoter stake change
- +0.01%
Other other announcement announcements
All →Rexpro Enterprises Other Announcement
Rexpro Enterprises filed the Acuité monitoring agency report for H1 FY2026-27 on IPO proceeds. The report flags delayed utilisation and an unused inorganic-growth object past its March 2026 timeline.
Nakoda Group Of Industries Other Announcement
Nakoda Group filed its quarterly Reg 32 statement on fund use from the preferential issue of 87,00,000 convertible warrants. It reports no deviation or variation, with ₹6.09 Crore received as the 25% upfront payment.
Arman Financial Services Other Announcement
Arman Financial Services disclosed its quarterly shareholding pattern as of 30 September 2026. Promoter and public holdings are reported in the standard Regulation 31 format.
Muthoot Microfin Other Announcement
Muthoot Microfin filed its quarterly shareholding pattern for the period ended 30 September 2026. Promoter and promoter group hold about 55.47%, with no transaction reported.
Hittco Tools Other Announcement
Hittco Tools filed its quarterly shareholding pattern for the quarter ended 30 September 2026. The filing discloses promoter, public and category-wise holdings.
Global Health Other Announcement
Global Health Ltd filed its quarterly shareholding pattern for the period ended September 30, 2026. This is a routine Regulation 31 compliance statement with no transaction or business event.